Bryan, Garnier & Co's News

Read all the news of the independent investment banking dedicated to Growth

Ipsen: Cabometyx approved by the FDA two months ahead of schedule

BUY-Top Picks, Fair Value EUR60 (+14%)

Published last April Tuesday 26, 2016

EDF: The curtain goes up

BUY, Fair Value EUR13,5 (+10%)

Published last April Monday 25, 2016
Bryan Garnier announces the succes of its annual TMT conference

Bryan Garnier announces the succes of its annual TMT conference

Published last March Wednesday 23, 2016

Amoéba: A development plan on track

CORPORATE

Published last March Monday 21, 2016

Worldline: The cheapest stock in our Payment coverage

BUY-Top Picks, Fair Value EUR29 (+34%)

Published last March Monday 21, 2016

Grandvision: Sounds fundamentals but in the optical industry acquisitions often cause dilution

BUY, Fair Value EUR29 vs. EUR29,5 (+17%)

Published last March Thursday 17, 2016

Axway Software: The remedial test

NEUTRAL, Fair Value EUR24 (+21%)

Published last March Thursday 17, 2016

The Essentials

Everything you need to know about investment banking dedicated to growth
Recent Transactions Highlights
From M&A, to IPOs see what’s been happening at Bryan, Garnier & Co this year
Join our Team
Bryan, Garnier & Co is always looking for talent in all our divisions, at all levels
Explore our opportunities